Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https://doi.org/10.1016/j.diabres.2021.109119.

Article  PubMed  Google Scholar 

Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81. https://doi.org/10.1016/j.diabres.2018.02.023.

Article  CAS  PubMed  Google Scholar 

Kerner W, Brückel J, German Diabetes Association. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(7):384–6. https://doi.org/10.1055/s-0034-1366278.

Article  CAS  PubMed  Google Scholar 

Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88–98. https://doi.org/10.1038/nrendo.2017.151.

Article  PubMed  Google Scholar 

Mondal R, Ritu RB, Banik PC. Prevalence of cardiovascular disease and its associated factors among middle-aged type-2 diabetic subjects: a cross-sectional study in selected hospitals in Bangladesh. Journal of Xiangya Medicine [Internet]. 2023 [cited 2024 May 31];8(0). https://doi.org/10.21037/jxym-22-36

Boonpor J, Pell JP, Ho FK, Celis-Morales C, Gray SR. In people with type 2 diabetes, Sarcopenia is associated with the incidence of cardiovascular disease: a prospective cohort study from the UK Biobank. Diabetes Obes Metab. 2024;26(2):524–31. https://doi.org/10.1111/dom.15338.

Article  CAS  PubMed  Google Scholar 

Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 - PubMed [Internet]. [cited 2024 May 31]. Available from: https://pubmed.ncbi.nlm.nih.gov/29884191/

Park SW, Goodpaster BH, Lee JS, Kuller LH, Boudreau R, de Rekeneire N, et al. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32(11):1993–7. https://doi.org/10.2337/dc09-0264.

Article  PubMed  PubMed Central  Google Scholar 

Park SW, Goodpaster BH, Strotmeyer ES, Kuller LH, Broudeau R, Kammerer C, et al. Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study. Diabetes Care. 2007;30(6):1507–12. https://doi.org/10.2337/dc06-2537.

Article  PubMed  Google Scholar 

Lb ML, L van der V, Jj H, van K AJ et al. R N,. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. Journal of the American Medical Directors Association [Internet]. 2013 [cited 2024 May 31];14(8). https://doi.org/10.1016/j.jamda.2013.02.006

Goodpaster BH, Park SW, Harris TB, Kritchevsky SB, Nevitt M, Schwartz AV, et al. The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol Biol Sci Med Sci. 2006;61(10):1059–64. https://doi.org/10.1093/gerona/61.10.1059.

Article  Google Scholar 

Kim TN, Park MS, Yang SJ, Yoo HJ, Kang HJ, Song W et al. Prevalence and determinant factors of Sarcopenia in patients with type 2 diabetes. Diabetes Care [Internet]. 2010 [cited 2024 May 31];33(7):1497–9. https://doi.org/10.2337/dc09-2310

Al Ozairi E, Alsaeed D, Al Roudhan D, Voase N, Pell JP, Ho FK, et al. A comparison of physical activity, muscle strength, and sleep between people with type 2 diabetes in Kuwait and the UK: a cross-sectional study. Front Endocrinol (Lausanne). 2022;13:1067227. https://doi.org/10.3389/fendo.2022.1067227.

Article  PubMed  Google Scholar 

Izzo A, Massimino E, Riccardi G, Della Pepa G. A narrative review on Sarcopenia in type 2 diabetes Mellitus: Prevalence and Associated factors. Nutrients. 2021;13(1):183. https://doi.org/10.3390/nu13010183.

Article  PubMed  PubMed Central  Google Scholar 

Liccini A, Malmstrom TK. Frailty and Sarcopenia as predictors of adverse health outcomes in persons with diabetes Mellitus. J Am Med Dir Assoc. 2016;17(9):846–51. https://doi.org/10.1016/j.jamda.2016.07.007.

Article  PubMed  Google Scholar 

Mesinovic J, Zengin A, De Courten B, Ebeling PR, Scott D. Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship. Diabetes Metab Syndr Obes. 2019;12:1057–72. https://doi.org/10.2147/DMSO.S186600.

Article  PubMed  PubMed Central  Google Scholar 

Feng L, Gao Q, Hu K, Wu M, Wang Z, Chen F, et al. Prevalence and risk factors of Sarcopenia in patients with diabetes: a Meta-analysis. J Clin Endocrinol Metab. 2022;107(5):1470–83. https://doi.org/10.1210/clinem/dgab884.

Article  PubMed  Google Scholar 

Qiao Y-S, Chai Y-H, Gong H-J, Zhuldyz Z, Stehouwer CDA, Zhou J-B et al. The Association between Diabetes Mellitus and Risk of Sarcopenia: accumulated evidences from Observational studies. Front Endocrinol (Lausanne) [Internet]. 2021 [cited 2024 Jun 1];12:782391. https://doi.org/10.3389/fendo.2021.782391

Anagnostis P, Gkekas NK, Achilla C, Pananastasiou G, Taouxidou P, Mitsiou M, et al. Type 2 diabetes Mellitus is Associated with increased risk of Sarcopenia: a systematic review and Meta-analysis. Calcif Tissue Int. 2020;107(5):453–63. https://doi.org/10.1007/s00223-020-00742-y.

Article  CAS  PubMed  Google Scholar 

Ai Y, Xu R, Liu L. The prevalence and risk factors of Sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetol Metab Syndr. 2021;13(1):93. https://doi.org/10.1186/s13098-021-00707-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereira S, Marliss EB, Morais JA, Chevalier S, Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes. 2008;57(1):56–63. https://doi.org/10.2337/db07-0887.

Article  CAS  PubMed  Google Scholar 

Russell ST, Rajani S, Dhadda RS, Tisdale MJ. Mechanism of induction of muscle protein loss by hyperglycaemia. Exp Cell Res. 2009;315(1):16–25. https://doi.org/10.1016/j.yexcr.2008.10.002.

Article  CAS  PubMed  Google Scholar 

Trierweiler H, Kisielewicz G, Hoffmann Jonasson T, Rasmussen Petterle R, Aguiar Moreira C. Zeghbi Cochenski Borba V. Sarcopenia: a chronic complication of type 2 diabetes mellitus. Diabetol Metab Syndr. 2018;10:25. https://doi.org/10.1186/s13098-018-0326-5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Veronese N, Stubbs B, Punzi L, Soysal P, Incalzi RA, Saller A, et al. Effect of nutritional supplementations on physical performance and muscle strength parameters in older people: a systematic review and meta-analysis. Ageing Res Rev. 2019;51:48–54. https://doi.org/10.1016/j.arr.2019.02.005.

Article  PubMed  Google Scholar 

Nowotny K, Jung T, Höhn A, Weber D, Grune T. Advanced Glycation End products and oxidative stress in type 2 diabetes Mellitus. Biomolecules [Internet]. 2015 [cited 2024 Jun 1];5(1):194. https://doi.org/10.3390/biom5010194

Twarda-Clapa A, Olczak A, Białkowska AM, Koziołkiewicz M. Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs. Cells [Internet]. 2022 [cited 2024 Jun 1];11(8). https://doi.org/10.3390/cells11081312

Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–70. https://doi.org/10.1161/CIRCRESAHA.110.223545.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chiu C-Y, Yang R-S, Sheu M-L, Chan D-C, Yang T-H, Tsai K-S, et al. Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway. J Pathol. 2016;238(3):470–82. https://doi.org/10.1002/path.4674.

Article  CAS  PubMed  Google Scholar 

Hirata Y, Nomura K, Senga Y, Okada Y, Kobayashi K, Okamoto S, et al. Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis. JCI Insight. 2019;4(4):e124952. https://doi.org/10.1172/jci.insight.124952.

Article  PubMed  PubMed Central  Google Scholar 

Merz KE, Thurmond DC. Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake. Compr Physiol [Internet]. 2020 [cited 2024 Jun 1];10(3):785–809. https://doi.org/10.1002/cphy.c190029

Chen H, Huang X, Dong M, Wen S, Zhou L, Yuan X. The Association between Sarcopenia and Diabetes: from pathophysiology mechanism to therapeutic strategy. Diabetes Metab Syndr Obes [Internet]. 2023;16:1541–54. https://doi.org/10.2147/DMSO.S410834. [cited 2024 Jun 1];.

Article  CAS  PubMed  Google Scholar 

Willems SM, Wright DJ, Day FR, Trajanoska K, Joshi PK, Morris JA, et al. Large-scale GWAS identifies multiple loci for hand grip strength providing biological insights into muscular fitness. Nat Commun. 2017;8:16015. https://doi.org/10.1038/ncomms16015.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hong S-H, Choi KM. Sarcopenic Obesity, insulin resistance, and their implications in Cardiovascular and metabolic consequences. Int J Mol Sci. 2020;21(2):494. https://doi.org/10.3390/ijms21020494.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scicchitano BM, Pelosi L, Sica G, Musarò A. The physiopathologic role of oxidative stress in skeletal muscle. Mech Ageing Dev. 2018;170:37–44. https://doi.org/10.1016/j.mad.2017.08.009.